Celyad Oncology S.A. CYAD

Set alert

Price alert · CYAD

All alert types
0.47 +0.47 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
14.24M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-0.11
Beta
1.69
Short ratio
11.46
Inst. own
29.15%
Dividend
0.00
Ex-div date
Earnings
Mar 23, 2023
50-d avg
0.662867
200-d avg
1.07
1y target
8.52

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for CYAD has not been loaded yet. Try again in a moment.

Analyst view

Consensus: hold

Hold
Price target (mean) 8.52
Ratings (0m) 2 2 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 2
  • 1 month ago 1
  • 2 months ago 1
  • 3 months ago 2

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CYAD analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.000.00 – 0.000.000.0%00.0%0
Next quarter0.000.00 – 0.000.000.0%00.0%0
Current year0.000.00 – 0.000.000.0%3.31K0.0%0
Next year0.000.00 – 0.000.000.0%9.88M+298833.5%0

Upgrades and downgrades

The latest rating changes

CYAD analyst upgrades and downgrades
DateFirmActionFromTo
Jan 11, 2022Wells FargoMaintained—Overweight
Aug 6, 2021HC Wainwright & Co.Maintained—Buy
May 10, 2021HC Wainwright & Co.Maintained—Buy
Mar 26, 2021JonesTradingDowngradeBuyHold
Dec 8, 2020HC Wainwright & Co.Maintained—Buy
Mar 26, 2020Wells FargoMaintained—Overweight
Mar 25, 2020H.C. WainwrightMaintained—Buy
Jul 2, 2018H.C. WainwrightInitiated—Buy
May 31, 2018SunTrust Robinson HumphreyInitiated—Buy
May 25, 2018Wells FargoInitiated—Outperform
Jul 5, 2016UBSDowngradeBuyNeutral
Aug 26, 2015UBSMaintained—Buy
Jul 14, 2015UBSInitiated—Buy